Healthcare
Moderna to Pay Up to $2.25B to Settle COVID Vaccine Patent Dispute
Moderna reaches deal with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its COVID-19 vaccine.
Amylyx Pharmaceuticals Focuses on Advancing Avexitide for Post-Bariatric Hypoglycemia
Company also provides updates on pipeline programs AMX0318, AMX0114, and AMX0035
Agios Pharmaceuticals Highlights 2026 Catalysts as PYRUKYND Thalassemia Launch Gains Early Traction
Company outlines upcoming clinical and regulatory milestones, discusses early commercial progress for thalassemia treatment.
